Elissa J. Schwartz serves as Executive at GALECTIN THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Elissa J. Schwartz has executed 2 insider transactions totaling $2.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 16, 2026 involved receiving (via award) 60,000 shares valued at $0.
Elissa J. Schwartz currently holds 60,000 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elissa J. Schwartz has been a net buyer of GALT stock. They have purchased $2.0K and sold $0 worth of shares.
Elissa J. Schwartz's most recent insider trade was on Jan 16, 2026, when they sold 60,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.00 |
| Discretionary |